 | • レポートコード：GIR-2104Z13745 • 出版社/出版日：GlobalInfoResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療・医薬品 |
| Single User | ￥504,600 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥756,900 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,009,200 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、治療用タンパク質のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。治療用タンパク質の種類別市場規模（モノクローナル抗体、エリスロポエチン、インスリン、インターフェロン、ヒト成長ホルモン、卵胞刺激ホルモン、血液凝固因子）、用途別市場規模（製薬会社、医療サービスプロバイダー、研究機関、学術研究所）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・治療用タンパク質の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Amgen、Abbott Laboratories、AstraZeneca、Baxter International、Boehringer Ingelheim、Chugai Pharmaceutical、Diasome Pharmaceuticals、Eli Lilly、GeneScience Pharmaceuticals、Generex Biotechnology、Genentech ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：モノクローナル抗体、エリスロポエチン、インスリン、インターフェロン、ヒト成長ホルモン、卵胞刺激ホルモン、血液凝固因子 ・用途別分析2016年-2026年：製薬会社、医療サービスプロバイダー、研究機関、学術研究所 ・治療用タンパク質の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・治療用タンパク質のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・治療用タンパク質のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・治療用タンパク質の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・治療用タンパク質の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Therapeutic Protein market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Therapeutic Protein size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Therapeutic Protein market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Therapeutic Protein market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Monoclonal Antibodies
Erythropoietin
Insulin
Interferon
Human Growth Hormone
Follicle Stimulating Hormone
Blood Clotting Factors
Market segment by Application can be divided into
Pharmaceutical Companies
Healthcare Service Providers
Research Organizations
Academic Research Institutes
The key market players for global Therapeutic Protein market are listed below:
Amgen
Abbott Laboratories
AstraZeneca
Baxter International
Boehringer Ingelheim
Chugai Pharmaceutical
Diasome Pharmaceuticals
Eli Lilly
GeneScience Pharmaceuticals
Generex Biotechnology
Genentech
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Therapeutic Protein Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Therapeutic Protein Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Monoclonal Antibodies
1.2.3 Erythropoietin
1.2.4 Insulin
1.2.5 Interferon
1.2.6 Human Growth Hormone
1.2.7 Follicle Stimulating Hormone
1.2.8 Blood Clotting Factors
1.3 Market Analysis by Application
1.3.1 Overview: Global Therapeutic Protein Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Pharmaceutical Companies
1.3.3 Healthcare Service Providers
1.3.4 Research Organizations
1.3.5 Academic Research Institutes
1.4 Global Therapeutic Protein Market Size & Forecast
1.4.1 Global Therapeutic Protein Sales in Value (2016-2026))
1.4.2 Global Therapeutic Protein Sales in Volume (2016-2026)
1.4.3 Global Therapeutic Protein Price by Type (2016-2026) & (USD/MT)
1.5 Global Therapeutic Protein Production Capacity Analysis
1.5.1 Global Therapeutic Protein Total Production Capacity (2016-2026)
1.5.2 Global Therapeutic Protein Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Therapeutic Protein Market Drivers
1.6.2 Therapeutic Protein Market Restraints
1.6.3 Therapeutic Protein Trends Analysis
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Amgen Details
2.1.2 Amgen Major Business
2.1.3 Amgen Therapeutic Protein Product and Services
2.1.4 Amgen Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Abbott Laboratories
2.2.1 Abbott Laboratories Details
2.2.2 Abbott Laboratories Major Business
2.2.3 Abbott Laboratories Therapeutic Protein Product and Services
2.2.4 Abbott Laboratories Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 AstraZeneca
2.3.1 AstraZeneca Details
2.3.2 AstraZeneca Major Business
2.3.3 AstraZeneca Therapeutic Protein Product and Services
2.3.4 AstraZeneca Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Baxter International
2.4.1 Baxter International Details
2.4.2 Baxter International Major Business
2.4.3 Baxter International Therapeutic Protein Product and Services
2.4.4 Baxter International Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Boehringer Ingelheim
2.5.1 Boehringer Ingelheim Details
2.5.2 Boehringer Ingelheim Major Business
2.5.3 Boehringer Ingelheim Therapeutic Protein Product and Services
2.5.4 Boehringer Ingelheim Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Chugai Pharmaceutical
2.6.1 Chugai Pharmaceutical Details
2.6.2 Chugai Pharmaceutical Major Business
2.6.3 Chugai Pharmaceutical Therapeutic Protein Product and Services
2.6.4 Chugai Pharmaceutical Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Diasome Pharmaceuticals
2.7.1 Diasome Pharmaceuticals Details
2.7.2 Diasome Pharmaceuticals Major Business
2.7.3 Diasome Pharmaceuticals Therapeutic Protein Product and Services
2.7.4 Diasome Pharmaceuticals Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Eli Lilly
2.8.1 Eli Lilly Details
2.8.2 Eli Lilly Major Business
2.8.3 Eli Lilly Therapeutic Protein Product and Services
2.8.4 Eli Lilly Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 GeneScience Pharmaceuticals
2.9.1 GeneScience Pharmaceuticals Details
2.9.2 GeneScience Pharmaceuticals Major Business
2.9.3 GeneScience Pharmaceuticals Therapeutic Protein Product and Services
2.9.4 GeneScience Pharmaceuticals Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Generex Biotechnology
2.10.1 Generex Biotechnology Details
2.10.2 Generex Biotechnology Major Business
2.10.3 Generex Biotechnology Therapeutic Protein Product and Services
2.10.4 Generex Biotechnology Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Genentech
2.11.1 Genentech Details
2.11.2 Genentech Major Business
2.11.3 Genentech Therapeutic Protein Product and Services
2.11.4 Genentech Therapeutic Protein Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Therapeutic Protein Sales by Manufacturer
3.1 Global Therapeutic Protein Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Therapeutic Protein Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Therapeutic Protein
3.4 Market Concentration Rate
3.4.1 Top 3 Therapeutic Protein Manufacturer Market Share
3.4.2 Top 6 Therapeutic Protein Manufacturer Market Share
3.5 Global Therapeutic Protein Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Therapeutic Protein Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Therapeutic Protein Market Size by Region
4.1.1 Global Therapeutic Protein Sales in Volume by Region (2016-2026)
4.1.2 Global Therapeutic Protein Revenue by Region (2016-2026)
4.2 North America Therapeutic Protein Revenue (2016-2026)
4.3 Europe Therapeutic Protein Revenue (2016-2026)
4.4 Asia-Pacific Therapeutic Protein Revenue (2016-2026)
4.5 South America Therapeutic Protein Revenue (2016-2026)
4.6 Middle East and Africa Therapeutic Protein Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Therapeutic Protein Sales in Volume by Type (2016-2026)
5.2 Global Therapeutic Protein Revenue by Type (2016-2026)
5.3 Global Therapeutic Protein Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Therapeutic Protein Sales in Volume by Application (2016-2026)
6.2 Global Therapeutic Protein Revenue by Application (2016-2026)
6.3 Global Therapeutic Protein Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Therapeutic Protein Sales by Type (2016-2026)
7.2 North America Therapeutic Protein Sales by Application (2016-2026)
7.3 North America Therapeutic Protein Market Size by Country
7.3.1 North America Therapeutic Protein Sales in Volume by Country (2016-2026)
7.3.2 North America Therapeutic Protein Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Therapeutic Protein Sales by Type (2016-2026)
8.2 Europe Therapeutic Protein Sales by Application (2016-2026)
8.3 Europe Therapeutic Protein Market Size by Country
8.3.1 Europe Therapeutic Protein Sales in Volume by Country (2016-2026)
8.3.2 Europe Therapeutic Protein Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Therapeutic Protein Sales by Type (2016-2026)
9.2 Asia-Pacific Therapeutic Protein Sales by Application (2016-2026)
9.3 Asia-Pacific Therapeutic Protein Market Size by Region
9.3.1 Asia-Pacific Therapeutic Protein Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Therapeutic Protein Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Therapeutic Protein Sales by Type (2016-2026)
10.2 South America Therapeutic Protein Sales by Application (2016-2026)
10.3 South America Therapeutic Protein Market Size by Country
10.3.1 South America Therapeutic Protein Sales in Volume by Country (2016-2026)
10.3.2 South America Therapeutic Protein Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Therapeutic Protein Sales by Type (2016-2026)
11.2 Middle East & Africa Therapeutic Protein Sales by Application (2016-2026)
11.3 Middle East & Africa Therapeutic Protein Market Size by Country
11.3.1 Middle East & Africa Therapeutic Protein Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Therapeutic Protein Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Therapeutic Protein Typical Distributors
12.3 Therapeutic Protein Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Therapeutic Protein Revenue by Type, (USD Million), 2021-2026
Table 2. Global Therapeutic Protein Revenue by Application, (USD Million), 2021-2026
Table 3. Amgen Basic Information, Manufacturing Base and Competitors
Table 4. Amgen Major Business
Table 5. Amgen Therapeutic Protein Product and Services
Table 6. Amgen Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Abbott Laboratories Basic Information, Manufacturing Base and Competitors
Table 8. Abbott Laboratories Major Business
Table 9. Abbott Laboratories Therapeutic Protein Product and Services
Table 10. Abbott Laboratories Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 12. AstraZeneca Major Business
Table 13. AstraZeneca Therapeutic Protein Product and Services
Table 14. AstraZeneca Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Baxter International Basic Information, Manufacturing Base and Competitors
Table 16. Baxter International Major Business
Table 17. Baxter International Therapeutic Protein Product and Services
Table 18. Baxter International Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 20. Boehringer Ingelheim Major Business
Table 21. Boehringer Ingelheim Therapeutic Protein Product and Services
Table 22. Boehringer Ingelheim Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Chugai Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Chugai Pharmaceutical Major Business
Table 25. Chugai Pharmaceutical Therapeutic Protein Product and Services
Table 26. Chugai Pharmaceutical Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Diasome Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 28. Diasome Pharmaceuticals Major Business
Table 29. Diasome Pharmaceuticals Therapeutic Protein Product and Services
Table 30. Diasome Pharmaceuticals Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 32. Eli Lilly Major Business
Table 33. Eli Lilly Therapeutic Protein Product and Services
Table 34. Eli Lilly Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. GeneScience Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. GeneScience Pharmaceuticals Major Business
Table 37. GeneScience Pharmaceuticals Therapeutic Protein Product and Services
Table 38. GeneScience Pharmaceuticals Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Generex Biotechnology Basic Information, Manufacturing Base and Competitors
Table 40. Generex Biotechnology Major Business
Table 41. Generex Biotechnology Therapeutic Protein Product and Services
Table 42. Generex Biotechnology Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Genentech Basic Information, Manufacturing Base and Competitors
Table 44. Genentech Major Business
Table 45. Genentech Therapeutic Protein Product and Services
Table 46. Genentech Therapeutic Protein Sales (K MT), Price (USD/MT), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Therapeutic Protein Sales by Manufacturer (2019-2021e) & (K MT)
Table 48. Global Therapeutic Protein Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Therapeutic Protein, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Therapeutic Protein Production Capacity by Company, (K MT): 2020 VS 2021
Table 51. Head Office and Therapeutic Protein Production Site of Key Manufacturer
Table 52. Global Therapeutic Protein Sales by Region (2016-2021e) & (K MT)
Table 53. Global Therapeutic Protein Sales by Region (2021-2026) & (K MT)
Table 54. Global Therapeutic Protein Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Therapeutic Protein Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Therapeutic Protein Sales by Type (2016-2021e) & (K MT)
Table 57. Global Therapeutic Protein Sales by Type (2021-2026) & (K MT)
Table 58. Global Therapeutic Protein Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Therapeutic Protein Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Therapeutic Protein Price by Type (2016-2021e) & (USD/MT)
Table 61. Global Therapeutic Protein Price by Type (2021-2026) & (USD/MT)
Table 62. Global Therapeutic Protein Sales by Application (2016-2021e) & (K MT)
Table 63. Global Therapeutic Protein Sales by Application (2021-2026) & (K MT)
Table 64. Global Therapeutic Protein Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Therapeutic Protein Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Therapeutic Protein Price by Application (2016-2021e) & (USD/MT)
Table 67. Global Therapeutic Protein Price by Application (2021-2026) & (USD/MT)
Table 68. North America Therapeutic Protein Sales by Country (2016-2021e) & (K MT)
Table 69. North America Therapeutic Protein Sales by Country (2021-2026) & (K MT)
Table 70. North America Therapeutic Protein Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Therapeutic Protein Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Therapeutic Protein Sales by Type (2016-2021e) & (K MT)
Table 73. North America Therapeutic Protein Sales by Type (2021-2026) & (K MT)
Table 74. North America Therapeutic Protein Sales by Application (2016-2021e) & (K MT)
Table 75. North America Therapeutic Protein Sales by Application (2021-2026) & (K MT)
Table 76. Europe Therapeutic Protein Sales by Country (2016-2021e) & (K MT)
Table 77. Europe Therapeutic Protein Sales by Country (2021-2026) & (K MT)
Table 78. Europe Therapeutic Protein Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Therapeutic Protein Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Therapeutic Protein Sales by Type (2016-2021e) & (K MT)
Table 81. Europe Therapeutic Protein Sales by Type (2021-2026) & (K MT)
Table 82. Europe Therapeutic Protein Sales by Application (2016-2021e) & (K MT)
Table 83. Europe Therapeutic Protein Sales by Application (2021-2026) & (K MT)
Table 84. Asia-Pacific Therapeutic Protein Sales by Region (2016-2021e) & (K MT)
Table 85. Asia-Pacific Therapeutic Protein Sales by Region (2021-2026) & (K MT)
Table 86. Asia-Pacific Therapeutic Protein Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Therapeutic Protein Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Therapeutic Protein Sales by Type (2016-2021e) & (K MT)
Table 89. Asia-Pacific Therapeutic Protein Sales by Type (2021-2026) & (K MT)
Table 90. Asia-Pacific Therapeutic Protein Sales by Application (2016-2021e) & (K MT)
Table 91. Asia-Pacific Therapeutic Protein Sales by Application (2021-2026) & (K MT)
Table 92. South America Therapeutic Protein Sales by Country (2016-2021e) & (K MT)
Table 93. South America Therapeutic Protein Sales by Country (2021-2026) & (K MT)
Table 94. South America Therapeutic Protein Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Therapeutic Protein Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Therapeutic Protein Sales by Type (2016-2021e) & (K MT)
Table 97. South America Therapeutic Protein Sales by Type (2021-2026) & (K MT)
Table 98. South America Therapeutic Protein Sales by Application (2016-2021e) & (K MT)
Table 99. South America Therapeutic Protein Sales by Application (2021-2026) & (K MT)
Table 100. Middle East & Africa Therapeutic Protein Sales by Country (2016-2021e) & (K MT)
Table 101. Middle East & Africa Therapeutic Protein Sales by Country (2021-2026) & (K MT)
Table 102. Middle East & Africa Therapeutic Protein Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Therapeutic Protein Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Therapeutic Protein Sales by Type (2016-2021e) & (K MT)
Table 105. Middle East & Africa Therapeutic Protein Sales by Type (2021-2026) & (K MT)
Table 106. Middle East & Africa Therapeutic Protein Sales by Application (2016-2021e) & (K MT)
Table 107. Middle East & Africa Therapeutic Protein Sales by Application (2021-2026) & (K MT)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Therapeutic Protein Typical Distributors
Table 111. Therapeutic Protein Typical Customers
List of Figures
Figure 1. Therapeutic Protein Picture
Figure 2. Global Therapeutic Protein Sales Market Share by Type in 2020
Figure 3. Monoclonal Antibodies
Figure 4. Erythropoietin
Figure 5. Insulin
Figure 6. Interferon
Figure 7. Human Growth Hormone
Figure 8. Follicle Stimulating Hormone
Figure 9. Blood Clotting Factors
Figure 10. Global Therapeutic Protein Sales Market Share by Application in 2020
Figure 11. Pharmaceutical Companies
Figure 12. Healthcare Service Providers
Figure 13. Research Organizations
Figure 14. Academic Research Institutes
Figure 15. Global Therapeutic Protein Market Size, (USD Million) & (K MT): 2020 VS 2021 VS 2026
Figure 16. Global Therapeutic Protein Market Size and Forecast (2016-2026) & (USD Million)
Figure 17. United States Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Canada Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Mexico Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Germany Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. France Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. United Kingdom Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Russia Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Italy Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. China Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Japan Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Korea Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. India Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Southeast Asia Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Australia Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Brazil Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Egypt Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 33. Saudi Arabia Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 34. South Africa Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 35. Turkey Therapeutic Protein Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 36. Global Therapeutic Protein Sales (2016-2026) & (K MT)
Figure 37. Global Therapeutic Protein Production Capacity (2016-2026) & (K MT)
Figure 38. Global Therapeutic Protein Production Capacity by Geographic Region: 2020 VS 2021
Figure 39. Therapeutic Protein Market Drivers
Figure 40. Therapeutic Protein Market Restraints
Figure 41. Therapeutic Protein Market Trends
Figure 42. Global Therapeutic Protein Sales Market Share by Manufacturer in 2020
Figure 43. Global Therapeutic Protein Revenue Market Share by Manufacturer in 2020
Figure 44. Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 45. Top 3 Therapeutic Protein Manufacturer (Revenue) Market Share in 2020
Figure 46. Top 6 Therapeutic Protein Manufacturer (Revenue) Market Share in 2020
Figure 47. Global Therapeutic Protein Sales Market Share by Region (2016-2026)
Figure 48. Global Therapeutic Protein Revenue Market Share by Region (2016-2026)
Figure 49. North America Therapeutic Protein Revenue (2016-2026) & (USD Million)
Figure 50. Europe Therapeutic Protein Revenue (2016-2026) & (USD Million)
Figure 51. Asia-Pacific Therapeutic Protein Revenue (2016-2026) & (USD Million)
Figure 52. South America Therapeutic Protein Revenue (2016-2026) & (USD Million)
Figure 53. Middle East & Africa Therapeutic Protein Revenue (2016-2026) & (USD Million)
Figure 54. Global Therapeutic Protein Sales Market Share by Type (2016-2026)
Figure 55. Global Therapeutic Protein Revenue Market Share by Type (2016-2026)
Figure 56. Global Therapeutic Protein Price by Type (2016-2026) & (USD/MT)
Figure 57. Global Therapeutic Protein Sales Market Share by Application (2016-2026)
Figure 58. Global Therapeutic Protein Revenue Market Share by Application (2016-2026)
Figure 59. Global Therapeutic Protein Price by Application (2016-2026) & (USD/MT)
Figure 60. North America Therapeutic Protein Sales Market Share by Country (2016-2026)
Figure 61. North America Therapeutic Protein Revenue Market Share by Country (2016-2026)
Figure 62. North America Therapeutic Protein Sales Market Share by Type (2016-2026)
Figure 63. North America Therapeutic Protein Sales Market Share by Application (2016-2026)
Figure 64. Europe Therapeutic Protein Sales Market Share by Country (2016-2026)
Figure 65. Europe Therapeutic Protein Revenue Market Share by Country (2016-2026)
Figure 66. Europe Therapeutic Protein Sales Market Share by Type (2016-2026)
Figure 67. Europe Therapeutic Protein Sales Market Share by Application (2016-2026)
Figure 68. Asia-Pacific Therapeutic Protein Sales Market Share by Region (2016-2026)
Figure 69. Asia-Pacific Therapeutic Protein Revenue Market Share by Region (2016-2026)
Figure 70. Asia-Pacific Therapeutic Protein Sales Market Share by Region (2016-2026)
Figure 71. Asia-Pacific Therapeutic Protein Sales Market Share by Application (2016-2026)
Figure 72. South America Therapeutic Protein Sales Market Share by Country (2016-2026)
Figure 73. South America Therapeutic Protein Revenue Market Share by Country (2016-2026)
Figure 74. South America Therapeutic Protein Sales Market Share by Type (2016-2026)
Figure 75. South America Therapeutic Protein Sales Market Share by Application (2016-2026)
Figure 76. Middle East & Africa Therapeutic Protein Sales Market Share by Country (2016-2026)
Figure 77. Middle East & Africa Therapeutic Protein Revenue Market Share by Country (2016-2026)
Figure 78. Middle East & Africa Therapeutic Protein Sales Market Share by Type (2016-2026)
Figure 79. Middle East & Africa Therapeutic Protein Sales Market Share by Application (2016-2026)
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
世界の組換え治療用抗体＆タンパク質市場規模・現状・予測（2021年-2027年） Therapeutic proteins are engineered in the laboratory for pharmaceutical use, including non-covalent binders. These proteins are highly effective and serve as modernized treatment for rare as well as chronic diseases. Protein therapeutics offer custom-made treatment approach by supporting a specific…- 世界のPEG化タンパク質治療薬市場規模・現状・予測（2021年-2027年） PEGylation is the process of covalent and non-covalent attachment of polyethylene glycol polymer chains to molecules, such as a drug, therapeutic protein, or vesicle. PEGylated protein therapeutics is estimated to show significant market growth during the forecast period, majorly due to the, growth …
- 世界の濾胞性リンパ腫治療薬市場規模・現状・予測（2021年-2027年） Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
- 世界のアデノシンデアミナーゼ欠損症（ADA）治療薬市場規模・現状・予測（2021年-2027年） Adenosine deaminase deficiency is an autosomal recessive metabolic disorder that causes immunodeficiency. It occurs in fewer than one in 100,000 live births worldwide. Market Analysis and Insights: Global Adenosine Deaminase Deficiency Therapeutic Market The global Adenosine Deaminase Deficiency The…
- 世界の生物学的治療薬市場規模・現状・予測（2021年-2027年） Biologic Therapeutic Drug are used for treatment of numerous diseases and conditions, and are the most advanced therapies. Market Analysis and Insights: Global Biologic Therapeutic Drug Market The global Biologic Therapeutic Drug market size is projected to reach US$ XX million by 2027, from US$ XX …